Electromedical Technologies (Electromedical Technologies) Cash-to-Debt : 0.05 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Electromedical Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Electromedical Technologies's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.05.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Electromedical Technologies couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Electromedical Technologies's Cash-to-Debt or its related term are showing as below:

EMED' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05 Med: 0.19 Max: 0.24
Current: 0.05

During the past 5 years, Electromedical Technologies's highest Cash to Debt Ratio was 0.24. The lowest was 0.05. And the median was 0.19.

EMED's Cash-to-Debt is ranked worse than
95.82% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs EMED: 0.05

Electromedical Technologies Cash-to-Debt Historical Data

The historical data trend for Electromedical Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Electromedical Technologies Cash-to-Debt Chart

Electromedical Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

0.19

0.24

0.19

0.05

Electromedical Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial														0.19	0.82	0.27	0.08	0.05

Competitive Comparison of Electromedical Technologies's Cash-to-Debt

For the Medical Devices subindustry, Electromedical Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromedical Technologies's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's Cash-to-Debt falls into.

Electromedical Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Electromedical Technologies's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.088	/	(1.442	+	0.256)
	=	0.05

Electromedical Technologies's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.088	/	(1.442	+	0.256)
	=	0.05

Electromedical Technologies (OTCPK:EMED) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Electromedical Technologies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Electromedical Technologies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Electromedical Technologies (Electromedical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromedical Technologies Inc (OTCPK:EMED) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

16561 North 92nd Street, Suite 101, Scottsdale, AZ, USA, 85260

Website

https://www.electromedtech.com

Electromedical Technologies Inc is a bioelectronics manufacturing company. It designs and develops simple-to-use bioelectronics therapy devices, which in major cases provide immediate and long-lasting pain relief across the broadest range of ailments. Its focuses on improving global wellness for people suffering from various painful conditions. It Develops and manufactures bioelectronics products.

Executives

Hymers Iii R. Leslie	director	520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Lee Benson	director	PO BOX 41828, MESA AZ 41828
Donald J Steinberg	10 percent owner	3223 SUMAC ROAD, FALLBROOK CA 92028
Matthew Wolfson	director, officer: CEO, CFO	16561 N. 92ND STREET, STE. 101, SCOTTSDALE AZ 85260